The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Weber Barbara since 2020.
This trader's CIK number is 1800670.
At the time of last reporting, Weber Barbara was the Chief Executive Officer of Tango Therapeutics, Inc.. (stock ticker symbol TNGX).
Also see all insider trading activities at Tango Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TNGX | 0 | $0 | 18,791 | $57,706 | 0 | $0 |
| 2024 | TNGX | 0 | $0 | 9,138 | $115,054 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RVMD | 0 | $0 | 5,200 | $249,714 | 0 | $0 |
| 2023 | RVMD | 0 | $0 | 15,000 | $526,005 | 15,000 | $43,875 |
| 2021 | RVMD | 0 | $0 | 15,672 | $714,332 | 15,672 | $35,602 |
| 2020 | RVMD | 0 | $0 | 12,000 | $414,796 | 12,000 | $13,438 |
1. Tango Therapeutics, Inc. (TNGX)
2. Revolution Medicines, Inc. (RVMD)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-04 | TNGX | Sale | 9,778 | 2.99 | 29,216 |
| 2025-02-05 | TNGX | Sale | 9,013 | 3.16 | 28,490 |
| 2024-02-06 | TNGX | Sale | 4,681 | 12.56 | 58,807 |
| 2024-02-07 | TNGX | Sale | 4,457 | 12.62 | 56,247 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-08 | RVMD | Sale | 5,200 | 48.02 | 249,714 |
| 2023-09-01 | RVMD | Sale | 15,000 | 35.07 | 526,005 |
| 2023-09-01 | RVMD | Option Ex | 15,000 | 2.92 | 43,875 |
| 2021-02-04 | RVMD | Sale | 5,000 | 50.94 | 254,700 |
| 2021-02-04 | RVMD | Option Ex | 5,000 | 4.73 | 23,650 |
| 2021-02-02 | RVMD | Option Ex | 5,336 | 1.12 | 5,976 |
| 2021-02-02 | RVMD | Sale | 5,336 | 45.00 | 240,120 |
| 2020-12-30 | RVMD | Sale | 5,336 | 41.14 | 219,512 |
| 2020-12-30 | RVMD | Option Ex | 5,336 | 1.12 | 5,976 |
| 2020-10-01 | RVMD | Option Ex | 2,000 | 1.12 | 2,240 |
| 2020-10-05 | RVMD | Sale | 7,196 | 36.17 | 260,315 |
| 2020-10-05 | RVMD | Option Ex | 7,196 | 1.12 | 8,059 |
| 2020-10-02 | RVMD | Sale | 804 | 36.02 | 28,959 |
| 2020-10-01 | RVMD | Sale | 2,000 | 34.76 | 69,522 |
| 2020-10-02 | RVMD | Option Ex | 804 | 1.12 | 900 |
| 2020-08-12 | RVMD | Option Ex | 1,667 | 1.12 | 1,867 |
| 2020-08-13 | RVMD | Option Ex | 333 | 1.12 | 372 |
| 2020-08-12 | RVMD | Sale | 1,667 | 28.00 | 46,676 |
| 2020-08-13 | RVMD | Sale | 333 | 28.00 | 9,324 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Weber Barbara (Chief Executive Officer of Tango Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.